Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease

被引:22
作者
Fernandes, Karla S. S. [1 ]
Brum, Doralina Guimaraes [2 ]
Sandrim, Valeria Cristina [1 ]
Guerreiro, Carlos Tostes [3 ]
Barreira, Amilton Antunes [2 ]
Tanus-Santos, Jose Eduardo [1 ]
机构
[1] Univ Sao Paulo, Dept Pharmacol Med & Rehabil Locomotor Apparat, Med Sch Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Dept Neurosci & Behav Med & Rehabil Locomotor App, Med Sch Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Dept Biomech Med & Rehabil Locomotor Apparat, Med Sch Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
关键词
Multiple sclerosis; Haplotypes; Matrix metalloproteinase-9; Polymorphism; EDSS; Pharmacogenetics; MMP-9 MICROSATELLITE POLYMORPHISM; ABDOMINAL AORTIC-ANEURYSM; CORONARY-ARTERY-DISEASE; GELATINASE B GENE; INTERFERON-BETA; MATRIX METALLOPROTEINASES; FUNCTIONAL POLYMORPHISM; CEREBROSPINAL-FLUID; PROMOTER; SUSCEPTIBILITY;
D O I
10.1016/j.jneuroim.2009.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is an autoimmune disease causing severe neurological disability. This study was carried out in order to determine whether the MMP-9 C-1562T and (CA)(13-25) polymorphisms are associated with MS. A total of 165 patients (92 whites/73 mulattos) and 191 controls (96 whites/95 mulattos) were enrolled in the study. While no difference in C-1562T polymorphism was observed between MS and healthy subjects, (CA)(n) genotypes and alleles were associated with MS. Moreover, the haplotypes are not associated with MS but seem to be relevant to the clinical status of MS. Thus the (CA)(n) polymorphism may contribute to MS susceptibility, but C-1562T and (CA)(n) haplotypes may modulate disease severity. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 35 条
[1]   Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes [J].
Avolio, C ;
Ruggieri, M ;
Giuliani, F ;
Liuzzi, GM ;
Leante, R ;
Riccio, P ;
Livrea, P ;
Trojano, M .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) :46-53
[2]   Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis [J].
Benesova, Yvonne ;
Vasku, Anna ;
Stourac, Pavel ;
Hladikova, Magdalena ;
Beranek, Michal ;
Kadanka, Zdenek ;
Novotna, Hana ;
Bednarik, Josef .
JOURNAL OF NEUROIMMUNOLOGY, 2008, 205 (1-2) :105-109
[3]   Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta [J].
Boz, C ;
Ozmenoglu, M ;
Velioglu, S ;
Kilinc, K ;
Orem, A ;
Alioglu, Z ;
Altunayoglu, V .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (02) :124-128
[4]   Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil [J].
Brum, Doralina Guimaraes ;
Barreira, Amilton Antunes ;
Louzada-Junior, Paulo ;
Mendes-Junior, Celso Teixeira ;
Donadi, Eduardo Antonio .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 189 (1-2) :118-124
[5]  
COMABELLA M, 2008, CLIN IMMUNOL, V20, P20
[6]   Definition and clinical importance of haplotypes [J].
Crawford, DC ;
Nickerson, DA .
ANNUAL REVIEW OF MEDICINE, 2005, 56 :303-+
[7]   Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [J].
Demacq, Caroline ;
Vasconcellos, Vivian B. ;
Marcaccini, Andrea M. ;
Gerlach, Raquel F. ;
Silva, Wilson A., Jr. ;
Tanus-Santos, Jose E. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (01) :57-63
[8]   Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis [J].
Fainardi, E ;
Castellazzi, M ;
Bellini, T ;
Manfrinato, MC ;
Baldi, E ;
Casetta, I ;
Paolino, E ;
Granieri, E ;
Dallocchio, F .
MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (03) :294-301
[9]   MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis [J].
Fiotti, N ;
Altamura, N ;
Fisicaro, M ;
Carraro, N ;
Uxa, L ;
Grassi, G ;
Torelli, L ;
Gobbato, R ;
Guarnieri, G ;
Baxter, BT ;
Giansante, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) :1330-1336
[10]   MMP-9 microsatellite polymorphism and multiple sclerosis [J].
Fiotti, N ;
Zivadinov, R ;
Altamura, N ;
Nasuelli, D ;
Bratina, A ;
Tommasi, MA ;
Bosco, A ;
Locatelli, L ;
Grop, A ;
Cazzato, G ;
Guarnieri, G ;
Giansante, C ;
Zorzon, M .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) :147-153